"It's a beautiful day in Zamunda"!
It is nice to see management being proactive today and creating a runway for future news. I have read the lawsuit twice and as a law school graduate, I am very impressed with it. There's just enough mentioning of patients in there for anyone reading this to understand the third party implications of the acts that are being alleged.
I think it is nice to see the stock trade in a relatively normal fashion. Retail and traders buying and a few traders likely selling for pennies and Shorty trying to keep the price down. That's how the market should work. Adding 300BPS to the cost of borrowing also brings a smile to my face. Not sure when we will see a more realistic valuation of NWBO, but the lawsuit news should bring in more retail and traders as the news of it spreads throughout the next week or so. This is 'free' advertisement to a market that is sick and tired of MM's and HF's screwing the little guy and in our case the patients too. I think the trading in the next week or two will be volatile as the shorts will not give up easily. It will be a lot harder for them now that they don't have the cover of MM's to assist them in the bear raids. I sure hope that we see a change from the MM's and not just short term until the 'dust settles'.
I have a question in general for the board. I will not be able to respond to this as I am only allowed to post once a day due to my previous violations of the rules, for which I am extremely remorseful (should any administrator read this).:
Do any of you think that there's not already a deal done (or at least outlined based on the combination trial) with Merck? Do you think they are going to sponsor a trial with Murcidencel without any guarantees from NWBO that they will have access to Murcidencel if the trial is successful? Do you think they will sponsor a trial with the knowledge that BMY or any other company could come in and buy NWBO, leaving them without access to Murcidencel? I would think that they have at least gotten a guarantee from NWBO that they will have future access to Murcidencel, in one form or the other. It doesn't have to be an exclusive partnership guarantee or a buy out promise, but they would at least have gotten a non-exclusive right to use Murcidencel with Keytruda if trial is successful. JMHO
As I am writing this, I can see we have moved up 3 cents during my longwinded post, which is always a good sign.
See you all tomorrow. Enjoy the good news and have a nice glass of wine tonight. Let's hope the market the next few days look at this as favorable as I do.
